TickerFactsScreenerDevelopers

Adaptimmune Therapeutics PLC (ADAPY) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$11.52M2015: -$24.64M2016: -$72.80M2017: -$80.66M2018: -$82.36M2019: -$139.77M2020: -$133.41M2021: -$162.25M2022: -$163.97M2023: -$139.74M2024: -$68.76M-$68.76M
2014Operating Income (USD)2024
Fiscal YearOperating IncomeChange YoY
2024-$68.76M+50.8%
2023-$139.74M+14.8%
2022-$163.97M-1.1%
2021-$162.25M-21.6%
2020-$133.41M+4.6%
2019-$139.77M-69.7%
2018-$82.36M-2.1%
2017-$80.66M-10.8%
2016-$72.80M-195.4%
2015-$24.64M-113.9%
2014-$11.52M—